![Elizabeth Barrett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Barrett
Directeur Général chez
UROGEN PHARMA LTD.
Fortune : 9 M $ au 31/05/2026
Profil
Elizabeth Barrett is currently President, Chief Executive Officer & Director at UroGen Pharma Ltd. since 2019, President & Chief Executive Officer at UroGen Pharma, Inc. since 2019, and Independent Director at Allogene Therapeutics, Inc. since 2021.
Former roles include Chief Executive Officer at Novartis Oncology, Inc. from 2018 to 2019, Chief Executive Officer at Medivation LLC (California), Independent Director at SAGE Therapeutics, Inc. from 2019 to 2025, Independent Director at Lifesci Acquisition II Corp., Vice President & GM-Oncology Business Unit at Cephalon LLC from 2006 to 2009, Global President & General Manager-Oncology at Pfizer Inc. from 2015 to 2019, Vice President-Critical Care & Surgery Franchise at Ortho Biotech, Inc., Vice President-Sales & Marketing at Veridex LLC, and VP & General Manager-Oncology Business Unit at Johnson & Johnson from 1993 to 2006.
Education includes an MBA from St. Joseph's University and undergraduate studies at the University of Louisiana at Lafayette.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UROGEN PHARMA LTD. 0,67% | 31/03/2026 | 326 691 ( 0,67% ) | 9 M $ | 31/05/2026 |
| 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Elizabeth Barrett
| Sociétés | Poste | Début |
|---|---|---|
| UROGEN PHARMA LTD. | Directeur Général | 03/01/2019 |
| ALLOGENE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/07/2021 |
UroGen Pharma, Inc.
 UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Directeur Général | 01/01/2019 |
Anciens postes connus de Elizabeth Barrett
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/07/2025 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2019 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Directeur Général | 01/01/2019 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/2009 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/05/2006 |
Formation de Elizabeth Barrett
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
St. Joseph's University
 St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisiana at Lafayette
 University of Louisiana at Lafayette Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
UroGen Pharma, Inc.
UroGen Pharma, Inc. BiotechnologyHealth Technology Operates as a biotech company that developing and commercializing innovative solutions to treat urothelial and specialty cancers | Health Technology |
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
